Legal Representation
Attorney
Richard M. LaBarge
USPTO Deadlines
Application History
39 eventsDate | Code | Type | Description |
---|---|---|---|
May 20, 2024 | MAB6 | E | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
May 20, 2024 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED |
Oct 18, 2023 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Oct 16, 2023 | EX4G | S | SOU EXTENSION 4 GRANTED |
Oct 16, 2023 | EXT4 | S | SOU EXTENSION 4 FILED |
Oct 16, 2023 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
Apr 20, 2023 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Apr 18, 2023 | EX3G | S | SOU EXTENSION 3 GRANTED |
Apr 18, 2023 | EXT3 | S | SOU EXTENSION 3 FILED |
Apr 18, 2023 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
Oct 21, 2022 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Oct 19, 2022 | EX2G | S | SOU EXTENSION 2 GRANTED |
Oct 19, 2022 | EXT2 | S | SOU EXTENSION 2 FILED |
Oct 19, 2022 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
Apr 26, 2022 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Apr 25, 2022 | EX1G | S | SOU EXTENSION 1 GRANTED |
Apr 25, 2022 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
Apr 19, 2022 | EXT1 | S | SOU EXTENSION 1 FILED |
Apr 19, 2022 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
Oct 19, 2021 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
Sep 5, 2021 | ETOP | T | EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED |
Aug 12, 2021 | CHPB | I | CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED |
Aug 12, 2021 | APET | A | ASSIGNED TO PETITION STAFF |
Aug 5, 2021 | EPPA | I | TEAS POST PUBLICATION AMENDMENT RECEIVED |
Jul 21, 2021 | ASCK | I | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
May 25, 2021 | ETOF | T | EXTENSION OF TIME TO OPPOSE RECEIVED |
Apr 27, 2021 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Apr 27, 2021 | PUBO | A | PUBLISHED FOR OPPOSITION |
Apr 7, 2021 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Mar 22, 2021 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER |
Mar 1, 2021 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
Mar 1, 2021 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Mar 1, 2021 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Aug 31, 2020 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Aug 31, 2020 | GNRT | F | NON-FINAL ACTION E-MAILED |
Aug 31, 2020 | CNRT | R | NON-FINAL ACTION WRITTEN |
Aug 24, 2020 | DOCK | D | ASSIGNED TO EXAMINER |
Jun 9, 2020 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
May 26, 2020 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 005
prescription pharmaceutical products, namely, calcifediol for treating symptoms from infection with the SARS-CoV-2 virus (COVID-19)
Classification
International Classes
005